So-Young International Inc. (SY) is the 290th largest of 300 Healthcare Services companies by market capitalisation, at 42.55 Mn, behind biote Corp. at 63.37 Mn. The table below compares all 300 on 8 financial metrics.
| # | Ticker | Company | match | industry_code | industry_group | industry_group_code | Market Capitalization | P/E | P/S | Enterprise Value |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | DVA | Davita Inc. | primary | H-14 | Healthcare Providers | HG-04 | 11.76 Bn | 10.23 | 0.84 | 12.64 Bn |
| 2 | RDNT | RadNet, Inc. | primary | H-14 | Healthcare Providers | HG-04 | 5.80 Bn | 298.26 | 2.55 | 5.37 Bn |
| 3 | CON | Concentra Group Holdings Parent, Inc. | primary | H-14 | Healthcare Providers | HG-04 | 4.40 Bn | 20.97 | 1.92 | 4.26 Bn |
| 4 | PRVA | Privia Health Group, Inc. | primary | H-14 | Healthcare Providers | HG-04 | 2.61 Bn | 77.08 | 1.11 | 2.25 Bn |
| 5 | MD | Pediatrix Medical Group, Inc. | primary | H-14 | Healthcare Providers | HG-04 | 2.20 Bn | 12.29 | 1.13 | 1.79 Bn |
| 6 | FMS | Fresenius Medical Care AG | primary | H-14 | Healthcare Providers | HG-04 | 2.11 Bn | 1.84 | 0.08 | 1.41 Bn |
| 7 | PGNY | Progyny, Inc. | primary | H-14 | Healthcare Providers | HG-04 | 2.01 Bn | 25.80 | 1.53 | 1.77 Bn |
| 8 | SGRY | Surgery Partners, Inc. | primary | H-14 | Healthcare Providers | HG-04 | 1.87 Bn | 22.43 | 0.55 | 3.08 Bn |
| 9 | USPH | U S Physical Therapy Inc /Nv | primary | H-14 | Healthcare Providers | HG-04 | 1.18 Bn | 23.92 | 1.45 | 1.47 Bn |
| 10 | STLN | Starling Oncology, Inc. | primary | H-14 | Healthcare Providers | HG-04 | 0.60 Bn | -20.01 | 1.01 | 0.55 Bn |
| 11 | EVH | Evolent Health, Inc. | primary | H-14 | Healthcare Providers | HG-04 | 0.49 Bn | -0.95 | 0.23 | 0.35 Bn |
| 12 | SRTA | Strata Critical Medical, Inc. | primary | H-14 | Healthcare Providers | HG-04 | 0.47 Bn | 11.40 | 1.84 | 0.45 Bn |
| 13 | SBC | SBC Medical Group Holdings Inc | primary | H-14 | Healthcare Providers | HG-04 | 0.42 Bn | 11.17 | 2.41 | 0.25 Bn |
| 14 | INFU | InfuSystem Holdings, Inc | primary | H-14 | Healthcare Providers | HG-04 | 0.24 Bn | 28.65 | 1.69 | 0.24 Bn |
| 15 | AIRS | Airsculpt Technologies, Inc. | primary | H-14 | Healthcare Providers | HG-04 | 0.20 Bn | -16.93 | 1.33 | 0.18 Bn |
| 16 | JYNT | JOINT Corp | primary | H-14 | Healthcare Providers | HG-04 | 0.12 Bn | 31.62 | 2.02 | 0.10 Bn |
| 17 | PIII | P3 Health Partners Inc. | primary | H-14 | Healthcare Providers | HG-04 | 0.07 Bn | -0.12 | 0.05 | 0.11 Bn |
| 18 | RYOJ | rYojbaba Co., Ltd. | primary | H-14 | Healthcare Providers | HG-04 | 0.06 Bn | -47.64 | 6.80 | 0.06 Bn |
| 19 | BTMD | biote Corp. | primary | H-14 | Healthcare Providers | HG-04 | 0.06 Bn | 6.76 | 0.35 | 0.06 Bn |
| 20 | SY | So-Young International Inc. | primary | H-14 | Healthcare Providers | HG-04 | 0.04 Bn | -0.58 | 0.17 | -0.07 Bn |
| 21 | DCGO | DocGo Inc. | primary | H-14 | Healthcare Providers | HG-04 | 0.04 Bn | -0.19 | 0.13 | -0.01 Bn |
| 22 | EUDA | EUDA Health Holdings Ltd | primary | H-14 | Healthcare Providers | HG-04 | 0.03 Bn | -9.10 | 3.74 | 0.03 Bn |
| 23 | LDDD | Longduoduo Co Ltd | primary | H-14 | Healthcare Providers | HG-04 | 0.02 Bn | -35.14 | 7.18 | 0.01 Bn |
| 24 | AMS | American Shared Hospital Services | primary | H-14 | Healthcare Providers | HG-04 | 0.01 Bn | -3.74 | 0.31 | 0.01 Bn |
| 25 | BMGL | Basel Medical Group Ltd | primary | H-14 | Healthcare Providers | HG-04 | 0.01 Bn | 10.77 | — | 0.01 Bn |
| 26 | LFST | LifeStance Health Group, Inc. | primary | H-14 | Healthcare Providers | HG-04 | 0.00 Bn | 0.09 | 0.00 | -0.22 Bn |
| 27 | CDIX | Cardiff Lexington Corp | primary | H-14 | Healthcare Providers | HG-04 | 0.00 Bn | — | — | 0.01 Bn |
| 28 | IVF | INVO Fertility, Inc. | primary | H-14 | Healthcare Providers | HG-04 | 0.00 Bn | -0.34 | 0.45 | 0.00 Bn |
| 29 | FCHS | First Choice Healthcare Solutions, Inc. | primary | H-14 | Healthcare Providers | HG-04 | 0.00 Bn | -0.05 | — | 0.00 Bn |
| 30 | NIVF | NewGenIvf Group Ltd | primary | H-14 | Healthcare Providers | HG-04 | 0.00 Bn | 0.00 | 0.01 | 0.00 Bn |
| 31 | JNJ | Johnson & Johnson | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 663.08 Bn | 31.49 | 6.77 | 642.33 Bn |
| 32 | ABBV | AbbVie Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 453.04 Bn | 71.80 | 7.04 | 446.51 Bn |
| 33 | MRK | Merck & Co., Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 370.87 Bn | 117.16 | 5.57 | 363.78 Bn |
| 34 | UNH | Unitedhealth Group Inc | secondary | H-18 | Healthcare Payers and Distributors | HG-05 | 359.38 Bn | 24.02 | 0.80 | 333.97 Bn |
| 35 | AMGN | Amgen Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 236.37 Bn | 27.00 | 6.20 | 222.38 Bn |
| 36 | ABT | Abbott Laboratories | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 187.42 Bn | 34.75 | 4.02 | 182.47 Bn |
| 37 | GILD | Gilead Sciences, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 187.38 Bn | -64.83 | 6.15 | 184.12 Bn |
| 38 | VRTX | Vertex Pharmaceuticals Inc / Ma | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 138.36 Bn | 31.45 | 10.99 | 130.51 Bn |
| 39 | ISRG | Intuitive Surgical Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 129.78 Bn | 41.12 | 11.76 | 124.69 Bn |
| 40 | CVS | CVS HEALTH Corp | secondary | H-18 | Healthcare Payers and Distributors | HG-05 | 123.65 Bn | 25.33 | 0.30 | 109.89 Bn |
| 41 | MDT | Medtronic plc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 120.53 Bn | 22.86 | 3.21 | 112.33 Bn |
| 42 | MCK | Mckesson Corp | secondary | H-19 | Healthcare Payers and Distributors | HG-05 | 105.79 Bn | 20.32 | 0.26 | 103.19 Bn |
| 43 | HCA | HCA Healthcare, Inc. | secondary | H-13 | Healthcare Providers | HG-04 | 88.28 Bn | 11.40 | 1.13 | 90.70 Bn |
| 44 | REGN | Regeneron Pharmaceuticals, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 85.09 Bn | 19.66 | 5.48 | 77.10 Bn |
| 45 | BSX | Boston Scientific Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 69.29 Bn | 19.13 | 3.30 | 68.99 Bn |
| 46 | RELX | Relx Plc | secondary | T-23 | Business Applications | TG-03 | 64.63 Bn | 5.22 | 4.50 | 64.32 Bn |
| 47 | ARGX | Argenx Se | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 63.93 Bn | 36.92 | 12.23 | 58.75 Bn |
| 48 | TEL | TE Connectivity plc | secondary | I-07 | Machinery | IG-02 | 60.39 Bn | 19.66 | 3.13 | 59.30 Bn |
| 49 | MRNA | Moderna, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 58.07 Bn | -18.38 | 26.07 | 52.94 Bn |
| 50 | AME | Ametek Inc/ | secondary | I-04 | Machinery | IG-02 | 54.50 Bn | 34.55 | 6.93 | 54.00 Bn |
| 51 | SNY | Sanofi | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 53.95 Bn | 11.58 | 1.01 | 46.98 Bn |
| 52 | EW | Edwards Lifesciences Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 51.83 Bn | 51.63 | 7.96 | 47.68 Bn |
| 53 | BDX | Becton Dickinson & Co | secondary | H-07 | Medical Devices and Diagnostics | HG-02 | 50.32 Bn | 53.89 | 2.16 | 49.46 Bn |
| 54 | HUM | Humana Inc | secondary | H-18 | Healthcare Payers and Distributors | HG-05 | 48.21 Bn | 35.13 | 0.33 | 24.40 Bn |
| 55 | NTRA | Natera, Inc. | secondary | H-17 | Healthcare Providers | HG-04 | 47.13 Bn | -244.55 | 17.41 | 46.03 Bn |
| 56 | VEEV | Veeva Systems Inc | secondary | T-27 | Vertical Software | TG-05 | 44.53 Bn | 44.00 | 12.88 | 37.29 Bn |
| 57 | IQV | Iqvia Holdings Inc. | secondary | H-11 | Pharma Services | HG-03 | 44.06 Bn | 33.68 | 2.59 | 42.11 Bn |
| 58 | TEVA | Teva Pharmaceutical Industries Ltd | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 42.34 Bn | 60.81 | 2.45 | 38.68 Bn |
| 59 | ONC | BeOne Medicines Ltd. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 40.49 Bn | 60.96 | 6.61 | 35.39 Bn |
| 60 | ROP | Roper Technologies Inc | secondary | T-19 | Business Applications | TG-03 | 40.28 Bn | 16.33 | 4.86 | 39.92 Bn |
| 61 | ALNY | Alnylam Pharmaceuticals, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 35.59 Bn | 45.89 | 7.41 | 32.28 Bn |
| 62 | ALC | Alcon Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 34.36 Bn | 29.19 | 3.19 | 32.91 Bn |
| 63 | DXCM | Dexcom Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 33.17 Bn | 33.61 | 6.68 | 31.23 Bn |
| 64 | CNC | Centene Corp | secondary | H-18 | Healthcare Payers and Distributors | HG-05 | 33.12 Bn | -6.48 | 0.16 | 6.13 Bn |
| 65 | RMD | Resmed Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 32.94 Bn | 21.82 | 5.83 | 31.47 Bn |
| 66 | BIIB | Biogen Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 32.63 Bn | 39.08 | 3.25 | 31.34 Bn |
| 67 | GEHC | GE HealthCare Technologies Inc. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 31.10 Bn | 15.21 | 1.46 | 29.22 Bn |
| 68 | INSM | INSMED Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 27.57 Bn | -31.36 | 24.23 | 26.41 Bn |
| 69 | BNTX | BioNTech SE | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 26.24 Bn | -14.72 | 8.48 | 12.58 Bn |
| 70 | INCY | Incyte Corp | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 25.47 Bn | 15.75 | 4.38 | 20.94 Bn |
| 71 | ROIV | Roivant Sciences Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 25.24 Bn | -16.96 | 2,310.98 | 25.93 Bn |
| 72 | GPN | Global Payments Inc | secondary | T-54 | Fintech | TG-09 | 24.60 Bn | -25.59 | 2.40 | 19.84 Bn |
| 73 | WST | West Pharmaceutical Services Inc | secondary | H-07 | Medical Devices and Diagnostics | HG-02 | 23.93 Bn | 43.80 | 7.19 | 23.49 Bn |
| 74 | STE | STERIS plc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 21.90 Bn | 27.13 | 3.63 | 21.43 Bn |
| 75 | THC | Tenet Healthcare Corp | secondary | H-13 | Healthcare Providers | HG-04 | 21.33 Bn | 9.87 | 0.98 | 21.30 Bn |
| 76 | SSNC | SS&C Technologies Holdings Inc | secondary | T-20 | Business Applications | TG-03 | 19.62 Bn | 23.78 | 2.99 | 19.26 Bn |
| 77 | ZBH | Zimmer Biomet Holdings, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 18.70 Bn | 22.24 | 2.20 | 18.30 Bn |
| 78 | NDSN | Nordson Corp | secondary | I-04 | Machinery | IG-02 | 17.73 Bn | 31.95 | 5.95 | 17.62 Bn |
| 79 | FTV | Fortive Corp | secondary | I-04 | Machinery | IG-02 | 17.23 Bn | 32.41 | 3.99 | 16.86 Bn |
| 80 | ASND | Ascendis Pharma A/S | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 16.77 Bn | -517.61 | 13.73 | 15.82 Bn |
| 81 | LDOS | Leidos Holdings, Inc. | secondary | I-02 | Aerospace and Defense | IG-01 | 16.70 Bn | 12.02 | 0.95 | 16.01 Bn |
| 82 | IEX | Idex Corp /De/ | secondary | I-10 | Machinery | IG-02 | 16.49 Bn | 31.87 | 4.60 | 15.87 Bn |
| 83 | JAZZ | Jazz Pharmaceuticals plc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 16.02 Bn | 16.58 | 3.48 | 14.40 Bn |
| 84 | NBIX | Neurocrine Biosciences Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 15.81 Bn | 22.28 | 4.69 | 15.42 Bn |
| 85 | MDGL | Madrigal Pharmaceuticals, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 15.77 Bn | -49.43 | 12.28 | 14.93 Bn |
| 86 | SOLV | Solventum Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 15.60 Bn | 11.03 | 1.88 | 15.19 Bn |
| 87 | TU | Telus Corp | secondary | C-01 | Telecommunications | CG-01 | 14.98 Bn | -23.58 | 0.68 | 14.45 Bn |
| 88 | EXEL | Exelixis, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 14.69 Bn | 17.20 | 6.03 | 13.85 Bn |
| 89 | BBIO | BridgeBio Pharma, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 14.62 Bn | -21.18 | 20.50 | 13.91 Bn |
| 90 | RVTY | Revvity, Inc. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 14.53 Bn | 61.18 | 4.99 | 13.51 Bn |
| 91 | SMMT | Summit Therapeutics Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 13.96 Bn | — | — | 13.27 Bn |
| 92 | COO | Cooper Companies, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 13.56 Bn | 57.55 | 3.21 | 13.42 Bn |
| 93 | BAX | Baxter International Inc | secondary | H-07 | Medical Devices and Diagnostics | HG-02 | 13.34 Bn | 579.94 | 1.20 | 11.16 Bn |
| 94 | BMRN | Biomarin Pharmaceutical Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 12.88 Bn | 176.35 | 3.78 | 12.00 Bn |
| 95 | PEN | Penumbra Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 12.69 Bn | 78.98 | 8.43 | 12.03 Bn |
| 96 | HALO | Halozyme Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 12.57 Bn | 31.25 | 7.55 | 12.34 Bn |
| 97 | ARWR | Arrowhead Pharmaceuticals, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 12.19 Bn | -45.49 | 18.20 | 10.58 Bn |
| 98 | KNSA | Kiniksa Pharmaceuticals International, plc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 12.15 Bn | 74.93 | 14.45 | 11.63 Bn |
| 99 | TEM | Tempus AI, Inc. | secondary | H-17 | Healthcare Providers | HG-04 | 11.32 Bn | -46.79 | 7.91 | 10.51 Bn |
| 100 | ALGN | Align Technology Inc | secondary | H-09 | Medical Devices and Diagnostics | HG-02 | 11.30 Bn | 27.42 | 2.73 | 10.20 Bn |
| 101 | AXSM | Axsome Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 10.81 Bn | -69.64 | 13.92 | 10.49 Bn |
| 102 | MOG-A | Moog Inc. | secondary | I-02 | Aerospace and Defense | IG-01 | 10.57 Bn | 31.21 | 2.45 | 10.50 Bn |
| 103 | GMED | Globus Medical Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 10.51 Bn | 19.74 | 3.34 | 9.91 Bn |
| 104 | GKOS | GLAUKOS Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 10.46 Bn | -66.34 | 17.06 | 10.34 Bn |
| 105 | PODD | Insulet Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 10.23 Bn | 27.22 | 3.35 | 9.69 Bn |
| 106 | APGE | Apogee Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 10.18 Bn | -34.62 | — | 9.20 Bn |
| 107 | GPCR | Structure Therapeutics Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 10.11 Bn | -54.84 | — | 10.11 Bn |
| 108 | HSIC | Henry Schein Inc | secondary | H-19 | Healthcare Payers and Distributors | HG-05 | 10.05 Bn | 24.14 | 0.74 | 10.80 Bn |
| 109 | RDY | Dr Reddys Laboratories Ltd | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 9.99 Bn | 789.75 | 2.73 | 9.85 Bn |
| 110 | PRAX | Praxis Precision Medicines, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 9.82 Bn | -26.87 | — | 9.06 Bn |
| 111 | IONS | Ionis Pharmaceuticals Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 9.62 Bn | -45.28 | 11.01 | 7.57 Bn |
| 112 | PTGX | Protagonist Therapeutics, Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 9.42 Bn | 87.02 | 33.42 | 9.42 Bn |
| 113 | ABVX | Abivax S.A. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 9.02 Bn | -21.45 | — | 9.02 Bn |
| 114 | PCVX | Vaxcyte, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 8.86 Bn | -8.36 | — | 8.86 Bn |
| 115 | OSCR | Oscar Health, Inc. | secondary | H-18 | Healthcare Payers and Distributors | HG-05 | 8.81 Bn | 17.69 | 0.58 | 0.26 Bn |
| 116 | UHS | Universal Health Services Inc | secondary | H-13 | Healthcare Providers | HG-04 | 8.77 Bn | 6.63 | 0.48 | 8.70 Bn |
| 117 | TGTX | Tg Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 8.57 Bn | 17.97 | 10.72 | 7.89 Bn |
| 118 | IBRX | ImmunityBio, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 8.51 Bn | -8.55 | 51.33 | 8.15 Bn |
| 119 | TXG | 10x Genomics, Inc. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 8.16 Bn | -108.40 | 13.23 | 7.61 Bn |
| 120 | ATR | Aptargroup, Inc. | secondary | I-04 | Machinery | IG-02 | 8.10 Bn | 22.34 | 2.06 | 7.93 Bn |
| 121 | IMVT | Immunovant, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 8.10 Bn | -14.99 | — | 8.10 Bn |
| 122 | SYRE | Spyre Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 7.84 Bn | -42.14 | — | 7.84 Bn |
| 123 | HNGE | Hinge Health, Inc. | secondary | H-16 | Healthcare Providers | HG-04 | 7.41 Bn | 68.00 | 10.30 | 7.03 Bn |
| 124 | CAI | Caris Life Sciences, Inc. | secondary | H-17 | Healthcare Providers | HG-04 | 7.08 Bn | 67.46 | 7.16 | 6.29 Bn |
| 125 | RYTM | Rhythm Pharmaceuticals, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 7.07 Bn | -33.52 | 29.47 | 6.74 Bn |
| 126 | BLRX | BioLineRx Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 6.97 Bn | -734.96 | 5,007.81 | 6.97 Bn |
| 127 | SRRK | Scholar Rock Holding Corp | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 6.73 Bn | -17.90 | — | 6.73 Bn |
| 128 | CGON | CG Oncology, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 6.59 Bn | -29.38 | 1,058.74 | 6.59 Bn |
| 129 | MMED | MiniMed Group, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 6.54 Bn | -12.66 | 2.15 | 6.24 Bn |
| 130 | MIRM | Mirum Pharmaceuticals, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 6.53 Bn | -7.43 | 10.57 | 6.10 Bn |
| 131 | BLCO | Bausch & Lomb Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 6.45 Bn | -39.59 | 1.21 | 6.14 Bn |
| 132 | NICE | NICE Ltd. | secondary | T-26 | Workplace Software | TG-04 | 6.38 Bn | 6.89 | 1.08 | 6.02 Bn |
| 133 | STVN | Stevanato Group S.p.A. | secondary | H-07 | Medical Devices and Diagnostics | HG-02 | 6.21 Bn | 35.67 | 4.35 | 6.11 Bn |
| 134 | COGT | Cogent Biosciences, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 5.96 Bn | -16.08 | — | 5.96 Bn |
| 135 | TFX | Teleflex Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 5.86 Bn | -5.34 | 2.60 | 5.56 Bn |
| 136 | DBVT | DBV Technologies S.A. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 5.84 Bn | -33.18 | 1,163.52 | 5.66 Bn |
| 137 | ORKA | Oruka Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 5.82 Bn | — | — | 4.09 Bn |
| 138 | XENE | Xenon Pharmaceuticals Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 5.78 Bn | -16.41 | — | 5.78 Bn |
| 139 | PTCT | Ptc Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 5.77 Bn | 15.04 | 5.72 | 3.55 Bn |
| 140 | LGND | Ligand Pharmaceuticals Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 5.69 Bn | 29.05 | 19.58 | 4.33 Bn |
| 141 | NOVT | Novanta Inc | secondary | I-04 | Machinery | IG-02 | 5.61 Bn | 114.99 | 5.45 | 4.89 Bn |
| 142 | EXLS | ExlService Holdings, Inc. | secondary | T-63 | Technology Services | TG-11 | 5.56 Bn | 22.34 | 2.48 | 5.27 Bn |
| 143 | MMSI | Merit Medical Systems Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 5.35 Bn | 36.75 | 3.39 | 4.90 Bn |
| 144 | GRFS | Grifols SA | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 5.31 Bn | 20.91 | 0.32 | 6.86 Bn |
| 145 | ERAS | Erasca, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 5.06 Bn | -17.55 | — | 5.06 Bn |
| 146 | RADX | Radiopharm Theranostics Ltd | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 4.92 Bn | -58.78 | 20,296.96 | 4.92 Bn |
| 147 | WAY | Waystar Holding Corp. | secondary | T-27 | Vertical Software | TG-05 | 4.81 Bn | 35.70 | 3.99 | 4.62 Bn |
| 148 | DOCS | Doximity, Inc. | secondary | T-27 | Vertical Software | TG-05 | 4.74 Bn | 28.79 | 7.23 | 4.05 Bn |
| 149 | CELC | Celcuity Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 4.68 Bn | -23.96 | — | 4.68 Bn |
| 150 | HAE | Haemonetics Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 4.68 Bn | 48.50 | 3.46 | 4.46 Bn |
| 151 | DNTH | Dianthus Therapeutics, Inc. /DE/ | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 4.63 Bn | — | — | 4.23 Bn |
| 152 | LIVN | LivaNova PLC | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 4.51 Bn | 23.76 | 3.06 | 3.99 Bn |
| 153 | CCC | CCC Intelligent Solutions Holdings Inc. | secondary | T-27 | Vertical Software | TG-05 | 4.41 Bn | 101.68 | 3.97 | 4.30 Bn |
| 154 | ITGR | Integer Holdings Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 4.30 Bn | 33.50 | 2.33 | 4.28 Bn |
| 155 | HTFL | Heartflow, Inc. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 4.24 Bn | -174.15 | 20.90 | 3.87 Bn |
| 156 | ICUI | Icu Medical Inc/De | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 4.19 Bn | 125.54 | 1.94 | 3.89 Bn |
| 157 | RLAY | Relay Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 4.16 Bn | -13.51 | 402.01 | 4.16 Bn |
| 158 | VKTX | Viking Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 4.07 Bn | -7.58 | — | 4.07 Bn |
| 159 | IRTC | iRhythm Holdings, Inc. | secondary | H-17 | Healthcare Providers | HG-04 | 4.05 Bn | -290.27 | 4.91 | 3.46 Bn |
| 160 | TLX | Telix Pharmaceuticals Ltd | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 4.04 Bn | — | — | 3.75 Bn |
| 161 | DYN | Dyne Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 4.02 Bn | -7.78 | — | 4.02 Bn |
| 162 | IOVA | Iovance Biotherapeutics, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 3.98 Bn | -18.93 | 12.25 | 3.68 Bn |
| 163 | IDYA | IDEAYA Biosciences, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 3.84 Bn | -16.67 | 16.41 | 3.01 Bn |
| 164 | AMLX | Amylyx Pharmaceuticals, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 3.80 Bn | -31.20 | — | 3.80 Bn |
| 165 | TNGX | Tango Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 3.79 Bn | -32.98 | 70.47 | 2.78 Bn |
| 166 | PLSE | Pulse Biosciences, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 3.77 Bn | -45.69 | 4,807.90 | 3.77 Bn |
| 167 | RCUS | Arcus Biosciences, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 3.77 Bn | -8.13 | 32.18 | 3.06 Bn |
| 168 | OPCH | Option Care Health, Inc. | secondary | H-15 | Healthcare Providers | HG-04 | 3.63 Bn | 17.68 | 0.64 | 3.43 Bn |
| 169 | DNLI | Denali Therapeutics Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 3.56 Bn | -8.16 | 987.61 | 3.56 Bn |
| 170 | ABCL | AbCellera Biologics Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 3.50 Bn | -21.21 | 52.94 | 3.50 Bn |
| 171 | CRVL | Corvel Corp | secondary | H-18 | Healthcare Payers and Distributors | HG-05 | 3.47 Bn | — | — | 3.12 Bn |
| 172 | IPGP | Ipg Photonics Corp | secondary | I-04 | Machinery | IG-02 | 3.32 Bn | 120.20 | 3.10 | 2.45 Bn |
| 173 | TMDX | TransMedics Group, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 3.12 Bn | 18.17 | 4.66 | 2.64 Bn |
| 174 | CLDX | Celldex Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 3.11 Bn | -10.05 | 19,714.47 | 3.11 Bn |
| 175 | IRON | Disc Medicine, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 3.04 Bn | -15.22 | — | 3.04 Bn |
| 176 | IMNM | Immunome Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 3.03 Bn | -11.21 | 593.06 | 2.51 Bn |
| 177 | WRBY | Warby Parker Inc. | secondary | D-10 | Apparel and Luxury | DG-04 | 3.00 Bn | 389.80 | 3.29 | 2.71 Bn |
| 178 | ARQT | Arcutis Biotherapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 3.00 Bn | 109.49 | 6.47 | 2.76 Bn |
| 179 | MBX | MBX Biosciences, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.96 Bn | -28.23 | — | 2.96 Bn |
| 180 | ZLAB | Zai Lab Ltd | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.94 Bn | -15.57 | 6.55 | 2.24 Bn |
| 181 | CHRN | ChronoScale Holdings Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 2.94 Bn | -55.84 | 41.09 | 2.93 Bn |
| 182 | ALHC | Alignment Healthcare, Inc. | secondary | H-18 | Healthcare Payers and Distributors | HG-05 | 2.81 Bn | 69.02 | 0.61 | 2.10 Bn |
| 183 | SLS | SELLAS Life Sciences Group, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.80 Bn | -80.78 | — | 2.80 Bn |
| 184 | ATAI | AtaiBeckley Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.73 Bn | -22.89 | 553.22 | 2.73 Bn |
| 185 | NRIX | Nurix Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.71 Bn | -8.51 | 73.73 | 2.27 Bn |
| 186 | TAK | Takeda Pharmaceutical Co Ltd | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.67 Bn | 4.61 | 0.06 | -3.12 Bn |
| 187 | ATRC | AtriCure, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 2.62 Bn | 237.62 | 4.60 | 2.45 Bn |
| 188 | CDNA | CareDx, Inc. | secondary | H-17 | Healthcare Providers | HG-04 | 2.62 Bn | 23.59 | 5.72 | 2.25 Bn |
| 189 | CURLF | Curaleaf Holdings, Inc. | secondary | S-09 | Tobacco and Cannabis | SG-04 | 2.61 Bn | -21.89 | 2.00 | 2.52 Bn |
| 190 | VRDN | Viridian Therapeutics, Inc.\DE | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.60 Bn | -6.02 | 36.49 | 2.60 Bn |
| 191 | AXGN | Axogen, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 2.59 Bn | -174.08 | 10.31 | 2.48 Bn |
| 192 | VERA | Vera Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.59 Bn | -6.44 | — | 2.59 Bn |
| 193 | WGS | GeneDx Holdings Corp. | secondary | H-17 | Healthcare Providers | HG-04 | 2.56 Bn | -24.02 | 5.64 | 2.43 Bn |
| 194 | ACHC | Acadia Healthcare Company, Inc. | secondary | H-13 | Healthcare Providers | HG-04 | 2.56 Bn | -2.93 | 0.76 | 2.60 Bn |
| 195 | BCRX | Biocryst Pharmaceuticals Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.54 Bn | -6.59 | 4.75 | 2.19 Bn |
| 196 | LIFE | Ethos Technologies Inc. | secondary | H-16 | Healthcare Providers | HG-04 | 2.54 Bn | -20.77 | 4.49 | 2.37 Bn |
| 197 | SUPN | Supernus Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.53 Bn | -29.70 | 3.21 | 2.16 Bn |
| 198 | HURN | Huron Consulting Group Inc. | secondary | I-26 | Business Services | IG-06 | 2.47 Bn | 21.78 | 1.76 | 2.44 Bn |
| 199 | HCM | HUTCHMED (China) Ltd | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.46 Bn | 3.27 | 3.41 | 2.47 Bn |
| 200 | HRMY | Harmony Biosciences Holdings, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.46 Bn | 13.72 | 2.56 | 1.65 Bn |
| 201 | BHC | Bausch Health Companies Inc. | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 2.45 Bn | -2.25 | 0.23 | 1.58 Bn |
| 202 | NKTR | Nektar Therapeutics | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.45 Bn | -20.64 | 44.92 | 1.77 Bn |
| 203 | XTLB | Xtl Biopharmaceuticals Ltd | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.38 Bn | -2,975.41 | — | 2.38 Bn |
| 204 | SRPT | Sarepta Therapeutics, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 2.38 Bn | -17.30 | 1.20 | 1.58 Bn |
| 205 | BHVN | Biohaven Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.37 Bn | -4.03 | — | 2.10 Bn |
| 206 | NUVB | Nuvation Bio Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.36 Bn | -21.96 | 13.89 | 2.36 Bn |
| 207 | OCUL | Ocular Therapeutix, Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.34 Bn | -7.91 | 44.88 | 2.34 Bn |
| 208 | PHVS | Pharvaris N.V. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.30 Bn | -23.50 | — | 1.93 Bn |
| 209 | FLYW | Flywire Corp | secondary | T-54 | Fintech | TG-09 | 2.26 Bn | 66.71 | 3.16 | 1.96 Bn |
| 210 | CLOV | Clover Health Investments, Corp. /De | secondary | H-18 | Healthcare Payers and Distributors | HG-05 | 2.25 Bn | -121.62 | 0.91 | 2.02 Bn |
| 211 | UFPT | Ufp Technologies Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 2.24 Bn | 30.92 | 3.54 | 2.23 Bn |
| 212 | KOD | Kodiak Sciences Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.22 Bn | -9.16 | — | 2.22 Bn |
| 213 | ESTA | Establishment Labs Holdings Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 2.21 Bn | -57.54 | 9.00 | 2.14 Bn |
| 214 | RAPP | Rapport Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.19 Bn | -15.84 | 109.75 | 2.19 Bn |
| 215 | ADMA | Adma Biologics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.17 Bn | 13.20 | 4.23 | 2.03 Bn |
| 216 | GMAB | Genmab A/S | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.16 Bn | 0.17 | 0.34 | 0.66 Bn |
| 217 | URGN | UroGen Pharma Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.16 Bn | -35.67 | 11.42 | 2.05 Bn |
| 218 | AUPH | Aurinia Pharmaceuticals Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.14 Bn | 6.66 | 6.86 | 1.69 Bn |
| 219 | NVCR | NovoCure Ltd | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 2.09 Bn | -14.01 | 2.99 | 1.65 Bn |
| 220 | ZYME | Zymeworks Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.08 Bn | -14.21 | 56.15 | 1.81 Bn |
| 221 | ZBIO | Zenas BioPharma, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.08 Bn | -4.99 | 2,082.32 | 2.08 Bn |
| 222 | VCEL | Vericel Corp | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 2.06 Bn | 81.80 | 6.71 | 1.89 Bn |
| 223 | XNCR | Xencor Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.98 Bn | -12.36 | 18.84 | 1.60 Bn |
| 224 | AGIO | Agios Pharmaceuticals, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.97 Bn | -4.78 | 20.06 | 1.97 Bn |
| 225 | RXRX | Recursion Pharmaceuticals, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.94 Bn | -3.72 | 35.35 | 1.39 Bn |
| 226 | VIR | Vir Biotechnology, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.93 Bn | -7.59 | 6.35 | 1.93 Bn |
| 227 | INOD | Innodata Inc | secondary | T-63 | Technology Services | TG-11 | 1.91 Bn | 31.88 | 6.03 | 1.66 Bn |
| 228 | ASTH | Astrana Health, Inc. | secondary | H-18 | Healthcare Payers and Distributors | HG-05 | 1.89 Bn | 54.09 | 0.49 | 1.25 Bn |
| 229 | LKFT | Lakefront Biotherapeutics NV | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.88 Bn | 0.01 | 1.63 | 1.88 Bn |
| 230 | STOK | Stoke Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.86 Bn | -9.47 | 67.43 | 1.57 Bn |
| 231 | IMCR | Immunocore Holdings plc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.86 Bn | -101.76 | 4.32 | 0.98 Bn |
| 232 | DMRA | Damora Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.86 Bn | -6.99 | — | 1.32 Bn |
| 233 | LMAT | Lemaitre Vascular Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.84 Bn | 28.08 | 7.03 | 1.47 Bn |
| 234 | SNDX | Syndax Pharmaceuticals Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.83 Bn | -10.09 | 7.27 | 1.29 Bn |
| 235 | INSP | Inspire Medical Systems, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.82 Bn | 13.46 | 2.03 | 1.50 Bn |
| 236 | CMPS | COMPASS Pathways plc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.80 Bn | -4.55 | — | 1.80 Bn |
| 237 | INBX | Inhibrx Biosciences, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.78 Bn | -14.23 | 1,370.98 | 1.78 Bn |
| 238 | BFLY | Butterfly Network, Inc. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 1.75 Bn | -25.77 | 15.62 | 1.62 Bn |
| 239 | GHRS | GH Research PLC | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.75 Bn | -27.67 | — | 1.39 Bn |
| 240 | SCNI | Scinai Immunotherapeutics Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.74 Bn | -207.39 | 1,008.79 | 1.73 Bn |
| 241 | BLFS | Biolife Solutions Inc | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 1.72 Bn | 29.73 | 16.76 | 1.64 Bn |
| 242 | TYRA | Tyra Biosciences, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.71 Bn | -12.73 | — | 1.71 Bn |
| 243 | NVAX | Novavax Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.68 Bn | -6.79 | 4.07 | 0.97 Bn |
| 244 | SEPN | Septerna, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.68 Bn | -118.55 | 16.97 | 1.68 Bn |
| 245 | AAPG | Ascentage Pharma Group International | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.66 Bn | -9.11 | 20.12 | 1.38 Bn |
| 246 | ANAB | Anaptysbio, Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.65 Bn | -68.24 | 8.28 | 1.36 Bn |
| 247 | FBRX | Forte Biosciences, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.58 Bn | -20.71 | — | 1.23 Bn |
| 248 | OMCL | Omnicell, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.57 Bn | 40.11 | 1.26 | 1.28 Bn |
| 249 | ARDT | Ardent Health, Inc. | secondary | H-13 | Healthcare Providers | HG-04 | 1.55 Bn | 9.16 | 0.24 | 1.22 Bn |
| 250 | BCAX | Bicara Therapeutics Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.53 Bn | -8.49 | — | 1.53 Bn |
| 251 | ABSI | Absci Corp | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.51 Bn | -11.47 | 969.66 | 1.31 Bn |
| 252 | RARE | Ultragenyx Pharmaceutical Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.51 Bn | -3.37 | 2.10 | 1.22 Bn |
| 253 | AVBP | ArriVent BioPharma, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.50 Bn | -9.00 | — | 1.50 Bn |
| 254 | KMTS | Kestra Medical Technologies, Ltd. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.49 Bn | -10.51 | 15.68 | 1.13 Bn |
| 255 | HCSG | Healthcare Services Group Inc | secondary | I-27 | Business Services | IG-06 | 1.48 Bn | 12.20 | 0.80 | 1.32 Bn |
| 256 | AGL | agilon health, inc. | secondary | H-18 | Healthcare Payers and Distributors | HG-05 | 1.48 Bn | -6.36 | 0.25 | 1.30 Bn |
| 257 | CNMD | CONMED Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.48 Bn | 26.25 | 1.08 | 1.44 Bn |
| 258 | ATEC | Alphatec Holdings, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.46 Bn | -13.45 | 1.79 | 1.34 Bn |
| 259 | INNV | InnovAge Holding Corp. | secondary | H-15 | Healthcare Providers | HG-04 | 1.46 Bn | -93.77 | 1.54 | 1.35 Bn |
| 260 | MAZE | Maze Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.45 Bn | -14.58 | 72.74 | 1.45 Bn |
| 261 | CGEM | Cullinan Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.42 Bn | -6.70 | — | 1.42 Bn |
| 262 | EVCM | EverCommerce Inc. | secondary | T-27 | Vertical Software | TG-05 | 1.40 Bn | 41.19 | 2.34 | 1.27 Bn |
| 263 | TNDM | Tandem Diabetes Care Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.38 Bn | -21.69 | 1.33 | 0.93 Bn |
| 264 | ALMS | Alumis Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.38 Bn | -5.85 | 165.97 | 0.88 Bn |
| 265 | AZTA | Azenta, Inc. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 1.37 Bn | -4.51 | 1.30 | 1.05 Bn |
| 266 | OMER | Omeros Corp | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.37 Bn | 80.09 | 35.55 | 1.37 Bn |
| 267 | VOR | Vor Biopharma Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.36 Bn | -1.48 | — | 1.36 Bn |
| 268 | ORIC | Oric Pharmaceuticals, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.33 Bn | -8.83 | — | 1.33 Bn |
| 269 | CLVT | Clarivate Plc | secondary | T-22 | Business Applications | TG-03 | 1.33 Bn | -3.98 | 0.55 | 1.11 Bn |
| 270 | AFYA | Afya Ltd | secondary | D-28 | Consumer Services | DG-09 | 1.33 Bn | 5.87 | 1.25 | 1.14 Bn |
| 271 | EYE | National Vision Holdings, Inc. | secondary | D-36 | Retail | DG-10 | 1.32 Bn | 47.85 | 0.67 | 1.29 Bn |
| 272 | DRTS | Alpha Tau Medical Ltd. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.32 Bn | 13.13 | — | 1.22 Bn |
| 273 | NUTX | Nutex Health Inc. | secondary | H-13 | Healthcare Providers | HG-04 | 1.32 Bn | 4.87 | 1.56 | 1.23 Bn |
| 274 | SDGR | Schrodinger, Inc. | secondary | T-27 | Vertical Software | TG-05 | 1.32 Bn | -27.62 | 5.09 | 0.90 Bn |
| 275 | PRCT | PROCEPT BioRobotics Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.30 Bn | -11.34 | 3.86 | 1.03 Bn |
| 276 | IART | Integra Lifesciences Holdings Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.30 Bn | -178.43 | 0.79 | 1.03 Bn |
| 277 | IMTX | Immatics N.V. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 1.28 Bn | -4.85 | 26.37 | 0.82 Bn |
| 278 | MLTX | MoonLake Immunotherapeutics | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.28 Bn | -4.18 | — | 0.74 Bn |
| 279 | JBIO | Jade Biosciences, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.26 Bn | -7.93 | — | 1.26 Bn |
| 280 | REPL | Replimune Group, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.26 Bn | -4.90 | — | 1.26 Bn |
| 281 | MNKD | Mannkind Corp | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.26 Bn | -28.78 | 3.20 | 1.15 Bn |
| 282 | THRM | Gentherm Inc | secondary | I-04 | Machinery | IG-02 | 1.25 Bn | 11.52 | 0.79 | 1.04 Bn |
| 283 | ANRO | Alto Neuroscience, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.25 Bn | -18.17 | — | 1.25 Bn |
| 284 | AORT | Artivion, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.25 Bn | -392.32 | 2.65 | 1.17 Bn |
| 285 | JANX | Janux Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.24 Bn | -12.42 | 51.51 | 1.24 Bn |
| 286 | UTI | Universal Technical Institute Inc | secondary | D-28 | Consumer Services | DG-09 | 1.23 Bn | 35.70 | 1.39 | 1.06 Bn |
| 287 | CERT | Certara, Inc. | secondary | T-27 | Vertical Software | TG-05 | 1.21 Bn | -17.92 | 2.96 | 1.03 Bn |
| 288 | CRVS | Corvus Pharmaceuticals, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.21 Bn | -27.82 | — | 1.00 Bn |
| 289 | GDRX | GoodRx Holdings, Inc. | secondary | T-27 | Vertical Software | TG-05 | 1.18 Bn | 72.66 | 1.51 | 0.89 Bn |
| 290 | CLYM | Climb Bio, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.18 Bn | -20.55 | — | 1.18 Bn |
| 291 | BVS | Bioventus Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.18 Bn | 15.53 | 2.03 | 1.20 Bn |
| 292 | GLUE | Monte Rosa Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.18 Bn | -9.12 | 41.06 | 0.55 Bn |
| 293 | STAA | Staar Surgical Co | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.18 Bn | 61.20 | 3.46 | 0.99 Bn |
| 294 | AVNS | Avanos Medical, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.17 Bn | -15.62 | 1.63 | 1.10 Bn |
| 295 | TDOC | Teladoc Health, Inc. | secondary | H-16 | Healthcare Providers | HG-04 | 1.14 Bn | -6.41 | 0.46 | 0.37 Bn |
| 296 | SVRA | Savara Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.10 Bn | -9.77 | — | 1.10 Bn |
| 297 | IRMD | Iradimed Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.07 Bn | 46.42 | 12.36 | 1.01 Bn |
| 298 | OKYO | OKYO Pharma Ltd | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.06 Bn | -118.02 | — | 1.06 Bn |
| 299 | PCRX | Pacira BioSciences, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.05 Bn | 71.04 | 1.41 | 0.80 Bn |
| 300 | ABUS | Arbutus Biopharma Corp | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.02 Bn | 6.67 | 5.60 | 0.93 Bn |